Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial

Detalles Bibliográficos
Autores principales: Wester, Ruth, Zweegman, Sonja, van der Holt, Bronno, Kersten, Marie José, Vellenga, Edo, van Marwijk-Kooy, Marinus, Asselbergs, Emelie, de Weerdt, Okke, Minnema, Monique C., Lonergan, Sarah, Palumbo, Antonio, Broijl, Annemiek, Sonneveld, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437562/
https://www.ncbi.nlm.nih.gov/pubmed/32885140
http://dx.doi.org/10.1097/HS9.0000000000000370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437562/
https://www.ncbi.nlm.nih.gov/pubmed/32885140
http://dx.doi.org/10.1097/HS9.0000000000000370

Ejemplares similares